相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Cannabinoid receptor 2 deficiency results in reduced neuroinflammation in an Alzheimer's disease mouse model
Anne-Caroline Schmoele et al.
NEUROBIOLOGY OF AGING (2015)
NEUROINFLAMMATION IN ALZHEIMER'S DISEASE; A SOURCE OF HETEROGENEITY AND TARGET FOR PERSONALIZED THERAPY
C. H. Latta et al.
NEUROSCIENCE (2015)
Synthesis and preliminary evaluation of a new fluorine-18 labelled triazine derivative for PET imaging of cannabinoid CB2 receptor
Laurent Hortala et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2014)
Cannabinoid receptor CB2 is expressed on vascular cells, but not astroglial cells in the post-mortem human Huntington's disease brain
Megan J. Dowie et al.
JOURNAL OF CHEMICAL NEUROANATOMY (2014)
Familial Alzheimer's disease-associated presenilin-1 alters cerebellar activity and calcium homeostasis
Diego Sepulveda-Falla et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Validating Antibodies to the Cannabinoid CB2 Receptor: Antibody Sensitivity Is Not Evidence of Antibody Specificity
Yannick Marchalant et al.
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2014)
Evaluation of the specificity of antibodies raised against cannabinoid receptor type 2 in the mouse retina
Bruno Cecyre et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2014)
Astroglial mGlu3 receptors promote alpha-secretase-mediated amyloid precursor protein cleavage
Daniela Durand et al.
NEUROPHARMACOLOGY (2014)
Cannabinoid CB2 receptors modulate midbrain dopamine neuronal activity and dopamine-related behavior in mice
Hai-Ying Zhang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Reversible Pathologic and Cognitive Phenotypes in an Inducible Model of Alzheimer-Amyloidosis
Tatiana Melnikova et al.
JOURNAL OF NEUROSCIENCE (2013)
Whole-Body Biodistribution and Radiation Dosimetry of the Cannabinoid Type 2 Receptor Ligand [11C]-NE40 in Healthy Subjects
Rawaha Ahmad et al.
MOLECULAR IMAGING AND BIOLOGY (2013)
CB2 Receptor Deficiency Increases Amyloid Pathology and Alters Tau Processing in a Transgenic Mouse Model of Alzheimer's Disease
Jeremy Koppel et al.
MOLECULAR MEDICINE (2013)
Microglial Beclin 1 Regulates Retromer Trafficking and Phagocytosis and Is Impaired in Alzheimer's Disease
Kurt M. Lucin et al.
NEURON (2013)
Janus-faced microglia: beneficial and detrimental consequences of microglial phagocytosis
Amanda Sierra et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2013)
Fiji: an open-source platform for biological-image analysis
Johannes Schindelin et al.
NATURE METHODS (2012)
New Criteria for Alzheimer Disease and Mild Cognitive Impairment Implications for the Practicing Clinician
Andrew E. Budson et al.
NEUROLOGIST (2012)
Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's Disease
Randall J. Bateman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Preclinical evaluation of [11C]NE40, a type 2 cannabinoid receptor PET tracer
Nele Evens et al.
NUCLEAR MEDICINE AND BIOLOGY (2012)
Excitability of prefrontal cortical pyramidal neurons is modulated by activation of intracellular type-2 cannabinoid receptors
Femke S. den Boon et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Inflammation in Alzheimer Disease-A Brief Review of the Basic Science and Clinical Literature
Tony Wyss-Coray et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2012)
Information processing during phagocytosis
David M. Underhill et al.
NATURE REVIEWS IMMUNOLOGY (2012)
Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
Reisa A. Sperling et al.
ALZHEIMERS & DEMENTIA (2011)
The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
Guy M. McKhann et al.
ALZHEIMERS & DEMENTIA (2011)
Synthesis, in vitro and in vivo evaluation of fluorine-18 labelled FE-GW405833 as a PET tracer for type 2 cannabinoid receptor imaging
Nele Evens et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2011)
A PET Brain Reporter Gene System Based on Type 2 Cannabinoid Receptors
Caroline Vandeputte et al.
JOURNAL OF NUCLEAR MEDICINE (2011)
Microglial phagocytosis induced by fibrillar β-amyloid is attenuated by oligomeric β-amyloid: implications for Alzheimer's disease
Xiao-dong Pan et al.
MOLECULAR NEURODEGENERATION (2011)
Activation of the innate immune receptor Dectin-1 upon formation of a 'phagocytic synapse'
Helen S. Goodridge et al.
NATURE (2011)
Anti-Aβ Therapeutics in Alzheimer's Disease: The Need for a Paradigm Shift
Todd E. Golde et al.
NEURON (2011)
Synthesis and biodistribution of [11C] A-836339, a new potential radioligand for PET imaging of cannabinoid type 2 receptors (CB2)
Andrew G. Horti et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2010)
CB2: a cannabinoid receptor with an identity crisis
Brady K. Atwood et al.
BRITISH JOURNAL OF PHARMACOLOGY (2010)
The endocannabinoid system and amyloid-related diseases
Lourdes Ruiz-Valdepenas et al.
EXPERIMENTAL NEUROLOGY (2010)
The activation of cannabinoid CB2 receptors stimulates in situ and in vitro beta-amyloid removal by human macrophages
Rosa Maria Tolon et al.
BRAIN RESEARCH (2009)
Characterization of a Cannabinoid CB2 Receptor-Selective Agonist, A-836339 [2,2,3,3-Tetramethyl-cyclopropanecarboxylic Acid [3-(2-Methoxy-ethyl)-4,5-dimethyl-3H-thiazol-(2Z)-ylidene]-amide], Using in Vitro Pharmacological Assays, in Vivo Pain Models, and Pharmacological Magnetic Resonance Imaging
Betty B. Yao et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2009)
Functional Expression of Brain Neuronal CB2 Cannabinoid Receptors Are Involved in the Effects of Drugs of Abuse and in Depression
Emmanuel S. Onaivi et al.
DRUG ADDICTION: RESEARCH FRONTIERS AND TREATMENT ADVANCES (2008)
CB2 receptors in the brain: role in central immune function
G. A. Cabral et al.
BRITISH JOURNAL OF PHARMACOLOGY (2008)
Cannabinoid CB2 receptors in human brain inflammation
C. Benito et al.
BRITISH JOURNAL OF PHARMACOLOGY (2008)
Amyloid Pathology Is Associated with Progressive Monoaminergic Neurodegeneration in a Transgenic Mouse Model of Alzheimer's Disease
Ying Liu et al.
JOURNAL OF NEUROSCIENCE (2008)
Rapid appearance and local toxicity of amyloid-β plaques in a mouse model of Alzheimer's disease
Melanie Meyer-Luehmann et al.
NATURE (2008)
Glial expression of cannabinoid CB2 receptors and fatty acid amide hydrolase are beta amyloid-linked events in Down's syndrome
E. Nunez et al.
NEUROSCIENCE (2008)
A novel approach for imaging brain-behavior relationships in mice reveals unexpected metabolic patterns during seizures in the absence of tissue plasminogen activator
Martine M. Mirrione et al.
NEUROIMAGE (2007)
Opposing control of cannabinoid receptor stimulation on amyloid-β-induced reactive gliosis:: In vitro and in vivo evidence
Giuseppe Esposito et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)
Attenuation of neuroinflammation and Alzheimer's disease pathology by liver x receptors
Noam Zelcer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Systemic LPS causes chronic neuroinflammation and progressive neurodegeneration
Liya Qin et al.
GLIA (2007)
Lipopolysaccharide and cyclic AMP regulation of CB2 cannabinoid receptor levels in rat brain and mouse RAW 264.7 macrophages
Somnath Mukhopadhyay et al.
JOURNAL OF NEUROIMMUNOLOGY (2006)
Cannabinoid CB2 receptors: Immunohistochemical localization in rat brain
JP Gong et al.
BRAIN RESEARCH (2006)
Cycloxygenase-2 activity promotes cognitive deficits but not increased amyloid burden in a model of Alzheimer's disease in a sex-dimorphic pattern
T. Melnikova et al.
NEUROSCIENCE (2006)
Identification and functional characterization of brainstem cannabinoid CB2 receptors
MD Van Sickle et al.
SCIENCE (2005)
Environmental enrichment mitigates cognitive deficits in a mouse model of Alzheimer's disease
JL Jankowsky et al.
JOURNAL OF NEUROSCIENCE (2005)
Episodic-like memory deficits in the APPswe/PS1dE9 mouse model of Alzheimer's disease:: Relationships to β-amyloid deposition and neurotransmitter abnormalities
A Savonenko et al.
NEUROBIOLOGY OF DISEASE (2005)
Stimulation of cannabinoid receptor 2 (CB2) suppresses microglial activation
Jared Ehrhart et al.
JOURNAL OF NEUROINFLAMMATION (2005)
Synthetic cannabinoid WIN55,212-2 inhibits generation of inflammatory mediators by IL-1β-stimulated human astrocytes
WS Sheng et al.
GLIA (2005)
Dynamic complexity of the microglial activation response in transgenic models of amyloid deposition: Implications for Alzheimer therapeutics
D Morgan et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2005)
A three-dimensional digital atlas database of the adult C57BL/6J mouse brain by magnetic resonance microscopy
Y Ma et al.
NEUROSCIENCE (2005)
Mutant presenilins specifically elevate the levels of the 42 residue β-amyloid peptide in vivo:: evidence for augmentation of a 42-specific γ secretase
JL Jankowsky et al.
HUMAN MOLECULAR GENETICS (2004)
Co-expression of multiple transgenes in mouse CNS: a comparison of strategies
JL Jankowsky et al.
BIOMOLECULAR ENGINEERING (2001)
2-arachidonoylglycerol and the cannabinoid receptors
T Sugiura et al.
CHEMISTRY AND PHYSICS OF LIPIDS (2000)
Cannabinoid receptors and the regulation of immune response
EV Berdyshev
CHEMISTRY AND PHYSICS OF LIPIDS (2000)
Immunomodulation by cannabinoids is absent in mice deficient for the cannabinoid CB2 receptor
NE Buckley et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2000)
分享论文
